SUTRO BIOPHARMA, INC.STROEarnings & Financial Report
Nasdaq · Health Care · Biological Products, (No Diagnostic Substances)
Sutro Biopharma, Inc. is a publicly traded biotechnology company headquartered in South San Francisco, California focused on clinical-stage drug discovery, development and manufacturing. Using a proprietary cell-free protein synthesis platform, Sutro is working on oncology therapeutics using protein engineering and rational design. Founded in 2003 under the name Fundamental Applied Biology, the company name changed to Sutro Biopharma in 2009. William Newell, CEO as of 2024, joined Sutro in Ja...
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 9.60% | 5.8M | — | 2024-01-24 |
| NOS. OF ABOVE PERSONS | 9.50% | 5.8M | — | 2024-02-13 |
| Adage Capital Partners, L.P. | 7.33% | 4.5M | ▲ +1.47pp | 2024-02-07 |
| The Vanguard Group | 5.11% | 4.2M | flat | 2024-11-12 |
| Point72 Asset Management, L.P. | 3.70% | 3.0M | ▼ -4.00pp | 2024-11-14 |
| Adage Capital Management, L.P. | 2.75% | 2.3M | — | 2024-11-12 |
| Integrated Core Strategies | 1.60% | 1.3M | ▼ -3.50pp | 2024-11-04 |
| Biotechnology Value Fund, L.P. | 0.00% | 869.4M | — | 2024-11-14 |
| Rubric Capital Management | 0.00% | 869.4M | ▼ -5.49pp | 2024-11-13 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-04 | David Pauling | Chief Admin. Ofcr. & GC | Option exercise | 675 | $0.00 | $0 |
| 2026-03-04 | Jane Chung | Chief Executive Officer | Option exercise | 788 | $0.00 | $0 |
| 2026-03-02 | Gerber Hans-Peter | CHIEF SCIENTIFIC OFFICER | Option exercise | 2.8K | $0.00 | $0 |
| 2026-03-02 | David Pauling | Chief Admin. Ofcr. & GC | Option exercise | 2.4K | $0.00 | $0 |
| 2026-03-02 | Jane Chung | Chief Executive Officer | Option exercise | 7.8K | $0.00 | $0 |
| 2026-03-01 | Gerber Hans-Peter | CHIEF SCIENTIFIC OFFICER | Option exercise | 1.1K | $0.00 | $0 |
| 2026-03-01 | David Pauling | Chief Admin. Ofcr. & GC | Option exercise | 500 | $0.00 | $0 |
| 2026-03-01 | David Pauling | Chief Admin. Ofcr. & GC | Option exercise | 842 | $0.00 | $0 |
| 2026-03-01 | Jane Chung | Chief Executive Officer | Option exercise | 688 | $0.00 | $0 |
| 2026-03-01 | Jane Chung | Chief Executive Officer | Option exercise | 2.5K | $0.00 | $0 |
1–10 of 10